Analysis of the Efficacy of Immunotherapy in Elderly Patients with Lung Cancer

Analysis of the Efficacy of Immunotherapy in Elderly Patients with Lung Cancer

Background and objective Immunotherapy represented by immune checkpoint inhibitors (ICIs) has become the standard treatment for patients with non-oncogenic advanced non-small cell lung cancer (NSCLC). While lung cancer is most prevalent in elderly patients, these patients are rarely included in pivo...

Full description

Bibliographic Details
Main Authors: Mengjun YU, Xiang GAO, Siyun FU, Hui ZHANG, Na QIN, Xuefeng HAO, Renjing JIN, Teng MA, Jinghui WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
elderly patient
immunotherapy
prognostic factor
safety
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.16

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.16

Similar Items